AGIOのROE（自己資本利益率）は？

Agios PharmのROEは-40.09%です。

AGIOの配当利回りは？

Agios Pharmの配当利回りは0.00%です。

AGIOの品質スコア（Quality Score）は？

当社のAIはAGIOの総合財務品質を100点中0点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

AGIOは今が買い時ですか？

当社AIのタイミングスコアは100点中56点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

AGIOはどのセクターに属しますか？

Agios PharmはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

AGIO (NASDAQ) 株価分析 | AGIOS PHARM

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-06-30)

AGIO AI Analysis Summary

Our AI summary for AGIO: Agios Pharm (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -40.09%, a dividend yield of 0.00%. Its financial Quality Score stands at 0/100 — fundamentals below the market average. The AI Timing Score is 56/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

AGIO

Agios Pharm

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 30.54

0.52 (1.73%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-40.1%

ROE

-37.1%

ROA

0.00%

Div Yield

AGIOS PHARM
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 30.54 Price 0.52 (1.73%) Day Change	NEWS SCORE: N/A

AGIO, ファンダメンタルスコアはnot good ( ファンダメンタル = 0) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

0 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Deepscope 分析

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	30.54
PBV / Sector	1.75 / 44,219.29
Earning Per Share	-7.01

PE / Sector	N/A / 19.28
PEG or PE/Growth / Sector	N/A / 1.23
Average 1M Daily Value	47.16 M GREAT
Average 1W Daily Value	54.09 M

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-418.24 / 98.22
NPM Average (%) / Sector	-455.36 / -1,697.63
NPM Change Average (%) / Sector	-111.66 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-37.11 / 185,260.96
ROA Average (%) / Sector	-16.94 / 36,684.70
ROA Change Average (%) / Sector	-67.25 / 422,221.66
ROE (%) / Sector	-40.09 / 243,762.23
ROE Average (%) / Sector	-19.09 / 48,758.47
ROE Change Average (%) / Sector	-64.45 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

登録情報

Analyze Date	2026-08-04 08:01:06
Symbol	AGIO
Name	AGIOS PHARM
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	59.70 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,792.25 / 9,645.64

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 88 Sidney Street, Cambridge, MA, United States, 02139

Phone: 617 649 8600

Website: https://www.agios.com

Employees: 539

Sector: Healthcare >> Biotechnology

Description: Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.